Allied Market Research


Hydroxyzine Imine Market

Hydroxyzine Imine Market Size, Share, Competitive Landscape and Trend Analysis Report, by Dosage Form and, by Indication : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central nervous system. This property aids hydroxyzine imine to treat anxiety and tension associated with psychoneurosis. Besides, it also acts as an antihistamine which reduces the actions of natural histamine in the body and hence can cure symptoms of itching, or hives on the skin. It is also used along with other medications given during and after general anesthesia to produce synergistic effects. Key factors driving the growth of this market are the increase in population with allergic reactions coupled with rise in geriatric population. However, side effects such as skin rash, dizziness, and severe seizure among others will impede the market growth. Moreover, technological advancements and the increase in R&D investments for the development of novel therapeutic drugs will create more lucrative opportunities for key market players.

The hydroxyzine imine market is segmented based on dosage for, indication and region. Based on dosage form this market is segmented into tablet, capsule, syrup and injection. Further, based on indication this market is segmented into urticaria, histamine-mediated pruritus and atopic or contact dermatoses. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players of the market included in the report are GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceutical Industries, Changzhou ComWin Fine Chemicals Co., Ltd., N&R Industries, Shanghai Ruizheng Chemical Technology Co., Ltd, Lupin Pharmaceuticals, Inc., OAK PHARMS INC., Novartis International AG and Impax Laboratories, Inc.

Key Benefits

  • The study provides an in-depth analysis of the global hydroxyzine imine market, with current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis¬†to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the market by product type elucidates the various forms of available hydroxyzine imine type.
  • Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.
  • By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Hydroxyzine Imine Market Report Highlights

Aspects Details
By Dosage Form
  • Tablet
  • Capsule
  • Syrup
  • Injection
By Indication
  • Urticaria
  • Histamine-Mediated Pruritus
  • Atopic or Contact Dermatoses
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

N&R Industries, Teva Pharmaceutical Industries, Impax Laboratories, Inc., OAK PHARMS INC., Lupin Pharmaceuticals, Inc., Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Shanghai Ruizheng Chemical Technology Co., Ltd, Changzhou ComWin Fine Chemicals Co., Ltd.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Hydroxyzine Imine Market

Global Opportunity Analysis and Industry Forecast, 2023-2032